Evolent Health (EVH) Misses Q3 EPS by 24c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts EVH Hot Sheet
Join SI Premium – FREE
Evolent Health (NYSE: EVH) reported Q3 EPS of $0.04, $0.24 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $621.4 million versus the consensus estimate of $627.17 million.
GUIDANCE:
Evolent Health sees FY2024 revenue of $2.55-2.575 billion, versus the consensus of $2.577 billion.
For earnings history and earnings-related data on Evolent Health (EVH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- FDA approves first once-weekly insulin for type 2 diabetes mellitus in pediatric patients
- Zefiro Methane closes C$5M non-brokered private placement
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
